Publications
- Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy2022 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring2022 | First Faculty of Medicine
- Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives2022 | First Faculty of Medicine
- Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy (August, 10.1007/s00228-021-03201-1, 2021) +12021 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function2021 | First Faculty of Medicine
- Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice2020 | First Faculty of Medicine, Faculty of Science
- Obesity-associated changes in drug pharmacokinetics2020 | First Faculty of Medicine
- Importance of vancomycin loading doses in intermittent infusion regimens2018 | First Faculty of Medicine
- Estimation of initial phenobarbital dosing in term neonates with moderate-to-severe hypoxic ischaemic encephalopathy following perinatal asphyxia2018 | First Faculty of Medicine
- Estimation of once-daily amikacin dose in critically ill adults2018 | First Faculty of Medicine
Loading network view...